Valuation: DBV Technologies

Market Cap 50Cr 56Cr 46Cr 42Cr 79Cr 5.38TCr 80Cr 555.94Cr 217.83Cr 2.74TCr 208.78Cr 204.22Cr 8.8TCr P/E 2026 *
-4.1x
P/E 2027 * -11.6x
Enterprise Value 43Cr 48Cr 40Cr 36Cr 69Cr 4.65TCr 69Cr 480.81Cr 188.39Cr 2.37TCr 180.57Cr 176.62Cr 7.61TCr EV / Sales 2026 *
119x
EV / Sales 2027 * 6.06x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.65%
1 week-11.87%
Current month-19.09%
1 month-25.88%
3 months-41.16%
6 months-52.11%
Current year-50.36%
1 week 1.68
Extreme 1.678
1.9
1 month 1.68
Extreme 1.678
2.29
Current year 1.68
Extreme 1.678
4.4
1 year 1.68
Extreme 1.678
4.5
3 years 0.51
Extreme 0.506
4.5
5 years 0.51
Extreme 0.506
9.88
10 years 0.51
Extreme 0.506
86.64
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 63 21/06/2016
Director/Board Member 60 15/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
29/07/26 Sell

Chief Technology Officer

-464 0.0002%
29/01/26 Sell

Chief Technology Officer

534 0.0003%
12/01/26
Baker Bros. Advisors LP
ExerciceCompany 5,46,09,792 27.1991%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-11.87%-35.21%-30.32% 56Cr
+0.83%+3.19%+41.49%+103.56% 1,05100Cr
+1.93%+2.11%+37.08%+65.09% 63TCr
+1.49%+5.19%+19.94%+85.69% 49TCr
+2.26%+0.90%+69.32%+40.53% 36TCr
+1.45%+3.50%+23.29%+41.62% 34TCr
+1.17%+2.37%+13.47%+33.64% 27TCr
+0.89%+1.08%-6.13%+9.29% 25TCr
+1.82%+2.94%+42.99%+52.95% 22TCr
+2.77%+4.44%+29.01%+98.99% 19TCr
Average +1.40%+1.09%+23.53%+50.10% 38.04TCr
Weighted average by Cap. +1.47%+2.44%+33.35%+69.00%

Financials

2026 *2027 *
Net sales 36L 40.3L 33.48L 30.46L 57.51L 39Cr 57.76L 4.03Cr 1.58Cr 20Cr 1.51Cr 1.48Cr 64Cr 6.23Cr 6.97Cr 5.79Cr 5.27Cr 9.95Cr 674.87Cr 9.99Cr 70Cr 27Cr 344.07Cr 26Cr 26Cr 1.1TCr
Net income -17Cr -20Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -195.07Cr -76Cr -962.58Cr -73Cr -72Cr -3.09TCr -13Cr -14Cr -12Cr -11Cr -20Cr -1.37TCr -20Cr -141.22Cr -55Cr -696.85Cr -53Cr -52Cr -2.24TCr
Net Debt -6.71Cr -7.51Cr -6.24Cr -5.68Cr -11Cr -727.11Cr -11Cr -75Cr -29Cr -370.7Cr -28Cr -28Cr -1.19TCr -12Cr -13Cr -11Cr -10Cr -19Cr -1.29TCr -19Cr -133.29Cr -52Cr -657.74Cr -50Cr -49Cr -2.11TCr
Projected Income Statement - Annual - DBV Technologies
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change Volume
09/26/09 €1.678 -0.65% 5,94,470
08/26/08 €1.689 -4.90% 8,04,790
07/26/07 €1.776 +0.28% 13,75,248
06/26/06 €1.771 -4.58% 12,11,484
05/26/05 €1.856 -2.52% 12,26,325
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - DBV Technologies
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.678EUR
Average target price
3.637EUR
Spread / Average Target
+116.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DBV Technologies